United States TelemedicineMarket Opportunities , 2011 - 2021
P h a r m a & H e a l t h c a r e C o n s u l t a n t s
2
© Pharmaion
S. No. Contents
1. Product Overview
2. Research Methodology
3. Analyst View
4. Global Telemedicine Market Overview
5. United States Telemedicine Market Overview
6. United States Telemedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Mode of Communication
6.2.3. By End User
6.2.5. By Region
6.2.6. By Organized Vs. Unorganized
7. United States Telemedicine Service Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End User
8. United States Telemedicine Technology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
T a b l e o f C o n t e n t s
3
© Pharmaion
S. No. Contents
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Push To Talk (PTT) Technology
10.2. Technological Upgradations Spurring Home Healthcare Solutions
10.3. Adoption of Tele-Wound Care
10.4. Pervasive Video
10.5. Technological Innovations
11. SWOT Analysis
12. Value Chain Analysis
13. Policy & Regulatory Landscape
14. United States Economic Profile
15. Competitive Landscape
15.1. Honeywell Life Care Solutions
15.2. Allscripts Healthcare Solutions, Inc.
15.3. 3M Health Information System
15.4. Cisco Systems, Inc.
15.5. Polycom, Inc.
15.6. AT&T, Inc.
T a b l e o f C o n t e n t s
4
© Pharmaion
S. No. Contents
15.7. Teladoc, Inc.
15.8. MDLIVE Inc.
15.9. AMD Global Telemedicine, Inc.
15.10. InTouch Technologies, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
T a b l e o f C o n t e n t s
5
© Pharmaion
P r o d u c t O v e r v i e w
Telemedicine
• Telemedicine is the use of telecommunication to exchange medical
information and provide healthcare services from one distant
location to another.
• Clinical services are delivered through internet by using video
conferencing, smart phones, e-mail, and other telecommunication
medias.
• Telemedicine is considered as a safe and worthwhile way to deliver
clinical information and healthcare services. It helps in eliminating
distance barriers, and also increases the access to medical services
for patients, especially those who are located in remote areas.
• By implementing telemedicine, the travel time of healthcare experts
and nurses can be avoided, and also the patients can save money
by avoiding hospitalization. Therefore, quality treatment is provided
at reduced cost.
• Following are the two end users of telemedicine:
Telehospital / Teleclinic: Uses telemedicine for inpatients i.e.
patients within the hospital
Telehome: Uses telemedicine for outpatients i.e. patients
outside the hospital
6
© Pharmaion
R e s e a r c h M e t h o d o l o g y
Primary Research
•Identifying Key Opinion Leaders
•Questionnaire Design
•In-depth Interviews
•Coverage across Value Chain market
Market Estimation & Forecasting
Bottom-Up or Top-down approach for Market size estimation
Historical trend examination
Impact analysis of drivers and challenges to market growth
Statistical evaluation to develop the actual forecast
Data Validation, Analysis and Interpretation
Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings
Preliminary Data Mining
Qualitative and Quantitative research
2016E 2017F 2018F 2019F 2020F 2021F
CAGR (2016E-2021F): XX%
US Telemedicine Market Opportunities, 2011 - 2021
Secondary Research
•Government websites
•Company annual reports
•White papers
•Investor presentation
•Financial reports
7
© Pharmaion
R e s e a r c h M e t h o d o l o g y
Baseline Methodology:
For the study of the United States telemedicine market, Pharmaion has gathered information through an
exhaustive search of credible databases prudently evaluated all the collected information and presented it in
the most accurate and detailed manner.
Primary Sources
Key Stakeholders:
Product/Brand Managers
Business Development
Managers
Regional Mangers
Regulatory Affairs Personnel
Marketing & Sales Managers
Head of Patient Support
Programme
Substantial data points for analysis, interpretation and market size estimation
Data Triangulation
(Data validation
through cross verification
from primary & secondary
sources)
Qualitative and quantitative data from company
website, financial reports, research articles, designed
questionnaires etc.
In-depth interviews of key stakeholders of
major companies
Secondary Sources
Analysis of Data from credible sources: Centres for Disease
Control and Prevention (CDC)
Association of American Medical Colleges (AAMC)
American Telemedicine Association (ATA)
8
© Pharmaion
R e s e a r c h M e t h o d o l o g y
United States Telemedicine Market - Market Size Estimation
United States Telemedicine market has been segmented into two categories, namely, Service andTechnology.
Service segment has been further categorized into sub-segments - Monitoring, Consultation,Diagnosis, Treatment and Others.
While, Technology segment has been classified into sub-segments - Hardware, Software and Network& Telecom.
Calculation of United States Telemedicine
Market Size
To
p-d
ow
n A
pp
ro
ach
Calculation of Segment
Market Size
Sub-Segment Market Size Calculation
Sub-Segment Market Share (From
Primary and Secondary
Research) * Segment Market
Size
Calculation of Sub-segment market size
9
© Pharmaion
I n d u s t r y B r i e f
US Telemedicine Market to Cross $ 13 billion by 2021
Increasing healthcare costs and growing incidence rate of chronic diseases coupled with growing technologicaladvancements to drive United States telemedicine market
According to Pharmaion report, “United States Telemedicine Market Opportunities, 2011 - 2021”, thetelemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market isanticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronicdiseases. Moreover, various reforms in the healthcare industry such as Patient Protection and Affordable CareAct (PPACA), growing technological advancements and increasing awareness among citizens regarding healthmanagement and cost effective patient monitoring are driving telemedicine services and technologies market inthe United States.
United States telemedicine market has been segmented into two categories – service and technology. Servicesegment dominated the United States telemedicine market in 2015, and is anticipated to continue its dominancethrough 2021. However, the telemedicine technology segment is projected to witness higher growth rate, invalue terms, during 2016 - 2021. In 2015, real time mode was the most preferred mode of communication fordelivering telemedicine services, as it is cost-effective and helps in saving time by avoiding unnecessaryemergency visits and hospitalizations.
“Telemedicine is anticipated to improve healthcare outcomes, reduce consumer expenditure and provide easyinteraction between healthcare service providers and patients. During the forecast period, with growingtechnological advancements, telemedicine will become more user-friendly, thereby aiding overall market growthin the United States. Moreover, growing adoption of technologies like Push-to-Talk (PTT), Tele-Wound Care andPervasive Video is further anticipated to boost the country’s telemedicine market over the next five years.” saidMs. Pritpal Kaur, Consultant with Pharmaion Consultants, a research based global management consulting firmfocused on pharma and healthcare industry.
10
© Pharmaion
S a m p l e D a t a - S n a p s h o t
10 20 30 40 50 60 70 80 90 100 110
2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F
United States Telemedicine Market Size, By Value, 2011-2021F (USD Billion)
United States Telemedicine Market Share, By Type, By Value, 2011-2021F
30% 31% 32% 33% 34% 35% 36% 37% 38% 39% 40%
70% 69% 68% 67% 66% 65% 64% 63% 62% 61% 60%
2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F
Service
Technology
United States Telehospital / Teleclinic Market Share, By Specialty, By Value, 2011-2021F
23% 24% 25% 26% 27% 28% 29% 30% 31% 32% 33%
3% 3% 3% 3% 3% 3% 2% 2% 2% 2% 2%9% 9% 9% 9% 9% 9% 8% 8% 8% 8% 8%10% 10% 10% 11% 11% 11% 11% 11% 12% 12% 12%
21% 22% 23% 24% 25% 26% 27% 28% 29% 30% 31%
34% 33% 32% 31% 30% 29% 28% 27% 26% 25% 24%
2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F
Teleradiology
Telecardiology
Telepsychology
Teledermatology
Telepathology
Others*
10 20 30 40 50
2011 2012 2013 2014 2015
North-East Region
1020
3040
50
2011 2012 2013 2014 2015
West Region
10 20 30 40 50
2011 2012 2013 2014 2015
Mid-West Region
10 20 30 40 50
20112012201320142015
South Region
United States Telemedicine Market Size, By Region, By Value, 2011-2015 (USD Billion)
United States Telemedicine Service Market Share, By End User, By Value, 2011-2021F
18% 19% 20% 21% 22% 23% 24% 25% 26% 27% 28%
82% 81% 80% 79% 78% 77% 76% 75% 74% 73% 72% Telehospital /TeleclinicTelehome
United States Telemedicine Service Market Size, By Value, 2011-2021F (USD Billion)
10 20 30 40 50 60 70 80 90 100 110
2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F2021F
Allscripts Healthcare Solutions, Inc. (NYSE: MDRX)
OWNERSHIP STRUCTURE
(2014)Institutional
Holdings, 100.00%
Wellington Mangement Group LLP, 17.00%
Iridian Asset Management LLC/CT, …
Blue Harbour …Vanguard Group …
Glenhill Advisors LLC, …
Others, 17.00%
R e p o r t O r d e r i n g
To View Sample OR Purchase Report
Report Price
Report Name: United States Telemedicine Market Opportunities,
2011 - 2021
License Type Price
Single User License $2500
Single User License Print $3000
Enterprise License $5000
11
12
© Pharmaion
A b o u t U s & D i s c l a i m e r
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
+1 646 862 0089
www.pharmaion.com
About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides itscustomers with high value market research and advisory services that helps them identify new market opportunities, growthengines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow markettrends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and anincreased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditionalmarket research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable andinteractive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market researchand consulting requirements.
Related Reports
India Stem Cell Market Forecast & Opportunities, 2020
India Infertility Treatment Market Forecast & Opportunities, 2020
Global Tissue Engineered Medical Device Market Forecast & Opportunities, 2020
Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation ismade that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has beenobtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee theaccuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from theuse of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. Theinformation herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicativeof relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require priorapproval of Pharmaion Consultants.
ASIA-PACIFIC
Pharmaion Consultants Pvt. Ltd.
A – 51, Sector 57, Noida, National Capital Region,
India - 201301
+91 - 120 - 452 3900
www.pharmaion.com